Cases & Deals

  • Home
  • Practices
  • Pharmaceutical company negotiates pre-clinical research agreement with Chinese CRO

Share

Pharmaceutical company negotiates pre-clinical research agreement with Chinese CRO

April 2010

Client(s) International pharmaceutical company

Jones Day advised a pharmaceutical company on a US$3.5 million pre-clinical research agreement with a Chinese CRO. The agreement contains complex incentive structures relating to the identification of a minimum number of scaffolds for lead optimization.

May 2026 Experience

Enhabit acquired by Kinderhook Industries

May 2026 Experience

Tineco secures Federal Circuit affirmance of ITC victory regarding wet-dry surface cleaning devices

May 2026 Experience

VSE Corporation acquires Precision Aviation Group for $2.025 billion

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.